CLINIGMA

Patients should be meaningfully involved throughout the medical product development process as partners who are experts in their own experience of their disease or condition and the ultimate consumers of medical products. Recent guidance issued by the US Food and Drug Administration (FDA) recognises that the collection of patient experience data is important because it provides an opportunity to inform medical product development and enhance regulatory decision-making to better address patients needs. Who we are Clinigma, previously known under the name Clinical Survey Outcomes, has the expertise to assist pharmaceutical companies who wish to comply with the FDAs advice on...

Qualitative research,clinical trial,exit interview,focus group,surveys,real world evidence,interview,market research,clinical study,interview,outcomes research,strategy,health economics,anthropology,patient reported outcomes,outcomes assessments,mixed method,co-creation,drug development,pharmaceutical,and patient-centricity

Clinigma operates in the Pharmaceutical manufacturing industry.

Clinigma's revenue is 11m - 100m

Clinigma has 11 - 50 employees.